Wilson Sonsini Goodrich & Rosati advised AssetWatch on the transaction. AssetWatch, Inc., the fast-growing leader of end-to-end predictive maintenance and condition monitoring solutions, announced the close...
AssetWatch’s $75 Million Series C Financing Round
Stately Bio’s $12 Million Seed Financing Round
Wilson Sonsini Goodrich & Rosati advised Stately Bio on the transaction. Stately Bio, a start-up developing cell therapies using an ML-powered live-cell imaging platform, emerged from...
Neurona Therapeutics’ $102 Million Oversubscribed Financing Round
Wilson Sonsini Goodrich & Rosati advised Neurona Therapeutics on the transaction. Neurona Therapeutics (Neurona), a clinical-stage, privately-held, biotherapeutics company developing regenerative cell therapies for disorders of...